Worldwide incidence of multidrug-resistant tuberculosis

被引：209

作者：

Dye, C ^{[1
]}

Espinal, MA ^{[1
]}

Watt, CJ ^{[1
]}

Mbiaga, C ^{[1
]}

Williams, BG ^{[1
]}

机构：

[1] WHO, CH-1211 Geneva 27, Switzerland

来源：

JOURNAL OF INFECTIOUS DISEASES | 2002年 / 185卷 / 08期

关键词：

D O I：

10.1086/339818

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Planning for tuberculosis (TB) control requires an assessment of the number and distribution of drug-resistant cases. This study used results of resistance surveys from 64 countries, together with data predictive of resistance rates from 72 others, to estimate the number of new multidrug-resistant (MDR) TB cases that occurred in 2000. By these methods, an estimated 273,000 (95% confidence limits, 185, 000 and 414, 000) new cases of MDR TB occurred worldwide in 2000, 3.2% of all new TB cases. The analysis provides the first comprehensive set of estimates of the MDR TB burden by country and globally.

引用

页码：1197 / 1202

页数：6

共 7 条

[1] Crawley MJ., 1993, GLIM ECOLOGISTS
[2] Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country
Dye, C
Scheele, S
Dolin, P
Pathania, V
Raviglione, RC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 677 - 686
[3] ESPINAL M, 2000, 2 WHO, P253
[4] Global trends in resistance to antituberculosis drugs
Espinal, MA
Laszlo, A
Simonsen, L
Boulahbal, F
Kim, SJ
Reniero, A
Hoffner, S
Rieder, HL
Binkin, N
Dye, C
Williams, R
Raviglione, MC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) : 1294 - 1303
[5] Public health - Responding to market failures in tuberculosis control
Gupta, R
Kim, JY
Espinal, MA
Caudron, JM
Pecoul, B
Farmer, PE
Raviglione, MC
[J]. SCIENCE, 2001, 293 (5532) : 1049 - 1051
[6] *WHO, 2001, GLOB TUB CONTR, P287
[7] *WORLD BANK, 2000, WORLD DEV REP ATT PO

← 1 →